Mycotoxins and child health: The need for health risk assessment

International Journal of Hygiene and Environmental Health

Volumn 212, Issue 4, 2009, Pages 347-368

  Sherif, Sherif O ^a   Salama, Emad E ^a   Abdel Wahhab, Mosaad A ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Aflatoxins; Child health; Mycotoxins; Risk analysis; Risk assessment

Indexed keywords

MYCOTOXIN;

CHILD; CHILD WELFARE; DOSE RESPONSE; HEALTH CARE POLICY; HUMAN; REVIEW; RISK ASSESSMENT; STATISTICAL MODEL;

CHILD; CHILD WELFARE; DOSE-RESPONSE RELATIONSHIP, DRUG; HEALTH POLICY; HUMANS; MODELS, STATISTICAL; MYCOTOXINS; RISK ASSESSMENT;

EID: 67349129698     PISSN: 14384639     EISSN: 1618131X     Source Type: Journal    
DOI: 10.1016/j.ijheh.2008.08.002     Document Type: Review

References (256)

1. Abdel-Wahhab M.A. Antioxidant and radical scavenging effects of garlic and cabbage extracts in rats fed ochratoxin-contaminated diet. J. Egypt. Med. Assoc. 83 (2000) 1-19
2. Abdel-Wahhab M.A., and Aly S.E. Antioxidants and radical scavenging properties of vegetable extracts in rats fed aflatoxin-contaminated diet. J. Agric. Food Chem. 51 (2003) 2409-2414
3. Abdel-Wahhab M.A., and Aly S.E. Antioxidant property of Nagilia sativa (Black cumin) and Syzygium aromaticum (Clove) in rats during Aflatoxicosis. J. Appl. Toxicol. 25 (2005) 218-223
4. Abdel-Wahhab M.A., Nada S.A., Farag I.M., Abbas N.F., and Amra H.A. Potential protective effect of HSCAS and Bentonite against dietary aflatoxicosis in rat: with special reference to chromosomal aberrations. Nat. Toxins 6 (1998) 211-218
5. Abdel-Wahhab M.A., Nada S.A., and Arbid M.S. Ochratoxicosis: prevention of developmental toxicity by l-methionine in the rats. J. Appl. Toxicol. 19 (1999) 7-12
6. Abdel-Wahhab M.A., Nada S.A., and Amra H.A. Effect of aluminosilicates and bentonite on aflatoxin-induced developmental toxicity in the rats. J. Appl. Toxicol. 19 (1999) 199-204
7. Abdel-Wahhab M.A., Hassan A.M., Amer H.A., and Naguib K.M. Prevention of fumonisin-induced maternal and developmental toxicity in rats by certain plant extracts. J. Appl. Toxicol. 24 (2004) 469-474
8. Abdel-Wahhab M.A., Abdel-Galil M.M., and Ellithey M.M. Melatonin counteracts oxidative stress in rats fed Ochratoxin A-contaminated diet. J. Pineal Res. 38 (2005) 130-135
9. Abdel-Wahhab M.A., Ahmed H.H., and Hagazi M.M. Prevention of aflatoxin B1-initiated hepatotoxicity in rat by marine algae extracts. J. Appl. Toxicol. 26 (2006) 229-238
10. 1-intitiated hepatic carcinogenicity. Afr. J. Trad. CAM 4 (2007) 248-256
11. 1 in breast-milk of UAE women. Ann. Trop. Paediatr. 23 3 (2003) 173-179
12. Abdulrazzaq Y.M., Osman N., and Ibrahim A. Fetal exposure to aflatoxins in the United Arab Emirates. Ann. Trop. Paediatr. 22 1 (2003) 3-9
13. Abid S., Hassen W., Achour A., Skhiri H., Maaroufi K., Ellouz F., Creppy E., and Bacha H. Ochratoxin A and human chronic nephropathy in Tunisia: is the situation endemic?. Hum. Exp. Toxicol. 22 2 (2003) 77-84
14. Ahmed H., Hendrickse R.G., Maxwell S.M., and Yakubu A.M. Neonatal jaundice with reference to aflatoxins: an aetiological study in Zaria, northern Nigeria. Ann. Trop. Paediatr. 15 1 (1995) 11-20
15. Ahmed H., Uakubu A.M., and Hendrikse R.G. Neonatal jaundice in Zaria, Nigeria - a second prospective study. West Afr. J. Med. 14 1 (1999) 15-23
16. Amla I., Kamala C.S., Gopalakirishna G.S., Jayaraj A.P., Sreenvasmursy V., and Parpia H.A.B. Cirrhosis in children from peanut real contaminated with aflatoxins. Am. J. Clin. Nutr. 24 (1971) 609-614
17. Anderson L.M., Diwan B.A., Fear N.T., and Roman E. Critical windows of exposure for children's health: cancer in human epidemiological studies and neoplasm in experimental animal models. Environ. Health Perspect. 108 Suppl. 3 (2000) 573-594
18. Arcella D., and Leclercq C. Modeling exposure to mycotoxins. In: Mogan N., and Olsen M. (Eds). Mycotoxins in Food, Detection and Control (2004), CRC Press, Woodhead Publishing Ltd, New York, Cambridge, England 32-48
19. Azziz-Baumgartner E., Lindblade K., Gieseker K., Rogers H.S., Kieszak S., Njapau H., Schleicher R., McCoy L.F., Misore A., DeCock K., Rubin C., and Slutsker L. Aflatoxin Investigative Group. Case control study of an acute aflatoxicosis outbreak, Kenya. Environ. Health Perspect. 113 (2005) 1779-1783
20. Bahat, R.V., Vasanti, S., 2003. Mycotoxin food safety risk in developing countries, Focus 2003, 10, brief 3, International Food Policy Research Institute, Washington, USA.
21. Bane D.P., Neumann E.J., Hall W.F., Harlan K.S., and Slife R.L. Relationship between fumonisin contamination of feed and mystery swine disease. A case-control study. Mycopathologia 117 (1992) 121-124
22. Barrett J.R. Mycotoxins: of molds and maladies. Environ. Health Perspect. Focus A (2000) 20-23
23. Barton H.A., Cogliano V.J., Flowers L., Valcovic L., Serzer R.W., and Woodruff T.J. Assessing susceptibility from early-life exposure to carcinogens. Environ. Health Perspect. 113 (2005) 1125-1133
24. Bearer C.F. Biomarkers in pediatric environmental health: a cross-cutting issue. Environ. Health Perspect. 106 Suppl. 3 (1998) 813-816
25. Bennett J.W., and Klich M. Mycotoxins. Clin. Microbiol. Rev. 16 (2003) 497-516
26. Besunder J.B., Reed M.D., and Blumer J.L. Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmachodynamic interface (Part I). Clin. Pharmacokinet. 14 (1988) 189-216
27. Bhat, R.V., Vasanthi, S., 2003. Mycotoxin food safety risks in developing countries. Food Safety in Food Security and Food Trade. Vision 2020 for Food, Agriculture and Environment, Focus 10, brief 3 of 17, pp. 1-2.
28. Bhat R.V., Beedu S.R., Ramakrishna Y., and Munshi K.L. Outbreak of trichothecene mycotoxicosis associated with consumption of mould-damaged wheat products in Kashmir Valley, India. Lancet 1 8628 (1989) 35-37
29. Bhatnager D., Yu J., and Ehrlich K.C. Fungal allergy and pathogenicity. In: Breitenbach M., Crameri R., and Lehrer SB. (Eds). Chemical Immunology vol. 81 (2002), Karger, Basel, Switzerland 167-206
30. Blount W.B. Turkey "X" disease. J. Br. Turk. Fed. 9 (1961) 52-54
31. Bressac B., Kew M., Wands J., and Ozturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 350 6317 (1991) 429-431
32. Bullerman L.B. Significance of mycotoxins to food safety and human health. J. Food Prot. 42 1 (1979) 65-86
33. Bullerman L.B. Processing effects on mycotoxins: introduction. In: DeVries J.W., Trucksess M.W., and Jackson L.S. (Eds). Mycotoxins and Food Safety. Advances in Experimental Medicine and Biology vol. 504 (2002), Kluwer Academic/Plenum Publishers, New York
34. Burghardt R.C., Barhoumi R., Lewis E.H., Bailey R.H., Pyle K.A., Clement B.A., and Phillips T.D. Patulin-induced cellular toxicity: a vital fluorescence study. Toxicol. Appl. Pharmacol. 112 (1992) 235-244
35. Busby W.F., and Wogan G.N. Aflatoxins. In: Searlek C.E. (Ed). Chemical Carcinogen vol. 2 (1984), American Chemical Society, Washington, DC 945-1136
36. CA, 1A, 1999. Codex Alimentarius: vol. 1A, General requirements. Second edition (revised 1999). Joint FAO/WHO Food standard program. Codex Alimentarius Commission, FAO/WHO, Rome.
37. Caballero-Granado F.J., Viciana P., Cordero E., Gomez-Vera M.J., del Nozal M., and Lopez-Cortes L.F. Ergotism related to concurrent administration of ergotamine tartrate and ritonavir in an AIDS patient. Antimicrob. Agents Chemother. 41 (1997) 1207-1210
38. Campbell T.C., and Hayes J.R. The role of aflatoxins metabolism in toxic lesion. Toxicol. Appl. Pharmacol. 35 (1976) 199-222
39. Carlson J.E. Children's environmental health research - an introduction. Environ. Health Perspect. 106 Suppl. 3 (1998) 787-794
40. Carlson J.Y., and Sokoloff K. Preventing child exposures to environmental Hazards: research and policy issues. Environ. Health Perspect. 103 Suppl. 6 (1995) 3-5
41. CAST, 2003. Mycotoxins: risks in plant, animal and human systems. Task Force Report no. 139. Council for Agricultural Science and Technology, Ames, IA, pp. 1-191.
42. CDC (Centers for Disease Control and Prevention). Outbreaks of gastrointestinal illness of unknown etiology associated with eating burritos - United States, October 1997-October 1998. Morb. Mortal. Wkly. Rep. 48 (1999) 210-213
43. CDC (Centers for Disease Control and Prevention). Update: pulmonary hemorrhage/hemosiderosis among infants, Cleveland, OH, 1993-1999. Morb. Mortal. Wkly. Rep. 49 (2000) 180-184
44. CDC (Centers for Disease Control and Prevention). Outbreak of aflatoxin poisoning eastern and central provinces, Kenya. Morb. Mortal. Wkly. Rep. 53-34 (2004) 790-793
45. Cordell G.A. Ergot Alkaloids. In: Introduction to Alkaloids: A Biogenetic Approach (1981), Wiley, New York pp. 622-654
46. Coulter J.B., Lamplugh S.M., Suliman G.I., Omer M.I., and Hendrickse R.G. Aflatoxins in human breast milk. Ann. Trop. Paediatr. 4 (1984) 61-66
47. Coulter J.B.S., Hendrickse R.G., Lamplugh S.M., Macfarlane S.B.J., Moody J.B., Omar M.I.A., Soliman G.I., and Williams T.E. Aflatoxins and kwashiorkor: clinical studies in Sudanese children. Trans. R. Soc. Trop. Med. Hyg. 80 (1986) 840-847
48. Davis N.D., and Diener U.L. Mycotoxins. In: Beuchat L.R. (Ed). Food and Beverage Mycology (1987), Van Nostrand Reinhold, New York 517-524
49. Denning D.W. Aflatoxin and human disease (A review). Adverse Drug React. Acute Poison. Rev. 6 4 (1987) 175-209
50. Denning D.W., Quiepo S.C., Altman D.G., Makarananda K., Neal G.E., Camallere E.L., Morgan M.R., and Tupasi T.E. Aflatoxin and outcome from acute lower respiratory infection in children in The Philippines. Ann. Trop. Paediatr. 15 3 (1995) 209-216
51. Dorne J.L.C.M., and Renwick A.G. The refinement of uncertainty/safety factors in risk assessment by the incorporation of data on toxicokinetic variability in humans. Toxicol. Sci. 86 1 (2005) 20-26
52. Dorne J.L., Walton K., and Renwick A.G. Human variability in xenobiotic metabolism and pathway-related uncertainty factors for chemical risk assessment: a review. Food Chem. Toxicol. 43 (2005) 203-416
53. Drew R.T., Boorman G.A., Haseman J.K., McConnel E.E., Busey W.M., and Moore J.A. The effect of age and exposure duration on cancer induction by a known carcinogen in rats, mice, and hamsters. Toxicol. Appl. Pharmacol. 68 (1983) 120-130
54. Eaton D.L., and Gallagher E.P. Mechanisms of aflatoxin carcinogenesis. Annu. Rev. Pharmacol. Toxicol. 34 (1994) 135-172
55. Eaton D.I., and Groopman J.D. The Toxicology of Aflatoxins: Human health, Veterinary and Agricultural Significance (1994), Academic Press Inc., New York pp. 365-381
56. EC (European Commission), 2004. Commission Regulation (EC) No. 683/2004 of 13 April 2004. Official Journal of European Communities No. L106/3.
57. Edler I., Poirier K., Doursan M., Mileson B., Nordman H., Renwick A., Slob W., Walton K., and Wurtzen G. Mathematical modeling and quantitative methods. Food Chem. Toxicol. 40 (2002) 283-326
58. 1 in human breast milk samples from Victoria, Australia and Thailand. Food Chem. Toxicol. 33 (1995) 173-179
59. EPA. US Environmental protection agency. Guidelines for developmental toxicity risk assessment. Fed. Regist. 56 (1991) 63798-63825
60. EPA. US Environmental protection agency reproductive toxicity risk assessment guidelines; notice. Fed. Regist. 61 (1996) 56274-56322
61. EPA, 1997. US Environmental protection agency. Exposure factors handbook (update to the May 1989 edition). US Environmental Protection Agency, Washington, DC, EPA/600/p-95/002.
62. Etzel R.A. Mycotoxins. J. Am. Med. Assoc. 287 (2002) 425-427
63. Etzel R.A. What the primary care pediatrician should know about syndromes associated with exposures to Mycotoxins. Curr. Probl. Pediatr. Adolescent Health Care 36 (2006) 282-305
64. Fan A.N., and Tomar R.S. Risk assessment of environmental chemicals in food. In: Shils M.E., Olson J.A., Shike M., and Ross A.C. (Eds). Modern Nutrition in Health and Disease. ninth ed (1999), Lippincott, Williams and Wilkins, USA 1861-1874 (Chapter 114)
65. FAO, 1991. Food Nutrition and Agriculture. Food for the Future, vol. 1. FAO, Rome.
66. FAO, 1996. Basic facts on the world cereal situation. Food Outlook, Rome 5/6.
67. FAO, 1998. Food quality and safety systems - a training manual on food hygiene and the hazard analysis and critical control point (HACCP) system. Food quality and standards service food and nutrition division. Food and Agriculture Organization of the United Nations, Rome.
68. FAO, 2001. FNP73, Manual of the application of HACCP system in mycotoxin prevention and control. FAO Food and Nutrition paper no. 73, FAO, Rome.
69. FAO, 2003. FNP76. Assuring food safety and quality: guidelines for strengthening national food control systems; Food and Nutrition Paper 76, FAO/WHO, Rome.
70. FAO, 2004. World wide regulations for mycotoxins in food and feed in 2003 - FAO, Food and Nutrition Paper (FNP) 81. FAO of the United Nations, Rome.
71. FAO, 2005. The State of Food Insecurity in the World 2005. Eradicating world hunger key to achieving the millennium development goals, The Food and Agriculture Organization of the United Nations, Rome.
72. FAO/WHO, 1995. Application of risk analysis to food standard issues: Report of the Joint FAO/WHO Expert Consultation Food Additives (JECFA), WHO, Geneva.
73. FAO/WHO, 2002. Global forum of food safety regulators. Proceedings of the Forum; editorial, Marrakech, Morocco, January 2002. FAO/WHO, Rome, pp. 28-30.
74. Fink G.J. Mycotoxins: their implications for human and animal health. Vet. Q. 21 4 (1999) 115-120
75. Forrest C.B., and Riley A.W. Childhood origins of adult health: a basis for life-course health policy. Health Aff. (Millwood) 23 (2004) 155-164
76. FSA, 2004. Survey of baby foods for mycotoxins. Food Standards Agency Chemical Safety Division, London.
77. Fukai Y.C., Hoshino K., Kameyama T., Yasui T., Toda C., and Nagiono H. Placental transfer of ochratoxin A and its cytoxic effect on the mouse embryonic brain. Food Chem. Toxicol. 60 (1987) 17-24
78. Fung F., and Clark R. Health effects of mycotoxins: a toxicological overview. J. Toxicol. 42 (2004) 217-234
79. Galal N., Gamal El-Din R.M., Arafa A., Mohamad I.M., and Abdel-Wahhab M.A. Aflatoxin levels in Egyptian neonates with unexplained neonatal jaundice: morbidity and correlation to maternal assays in breast milk. Egypt. J. Neonatol. 7 3 (2006) 161-169
80. GAO, 2006. United States Government Accountability Office: Report to the Chairman, Committee on Environment and Public Works, US Senate Human Health Risk Assessment: EPA has taken steps to strengthen its process, but improvements needed in planning, data development, and training, GAO-06-595. United States Government Accountability Office, Washington, DC.
81. Gilbert J. Quality assurance in mycotoxin analysis. FNA 23 (1999) 33-37
82. Gilbert J., and Anklham E. Validation of analytical methods for determining mycotoxins in foodstuffs. Trends Anal. Chem. 21 (2002) 468-486
83. Ginsberg G., Hattis D., Sonawane B., Russ A., Banati P., Kozlak M., Smolenski S., and Goble R. Evaluation of child/adult pharmacokinetic differences from a database derived from the therapeutic drug literature. Toxicol. Sci. 66 (2002) 185-200
84. Goldblatt L.A. Aflatoxins, Scientific Background, Control and Implications (1969), Academic Press, New York, London
85. Golden M.H., and Ramadath D. Free radicals in the pathogenesis of Kwashiorkor. Proc. Nutr. Soc. 46 (1987) 53-68
86. Gong Y., Cardwell K., Hounsa A., Egal S., Turner P.C., Hall A.J., and Wild C.P. Dietary aflatoxin exposure and impaired growth in young children from Benin and Togo: cross sectional study. BMJ 325 7354 (2002) 20-21
87. Gong Y.Y., Egal S., Hounsa A., Turner P.C., Hall A.J., Cardwell K.F., and Wild C.P. Determinants of aflatoxin exposure in young children from Benin and Togo, West Africa: the critical role of weaning. Int. J. Epidemiol. 32 4 (2003) 556-562
88. Gong Y., Hounsa A., Egal S., Turner P.C., Sutcliffe A.E., Hall A.J., Cardwell K., and Wild C.P. Postweaning exposure to aflatoxin results in impaired child growth: a longitudinal study in Benin, West Africa. Environ. Health Perspect. 112 (2004) 1334-1338
89. Groopman J.D. Molecular dosimetry methods for assessing human aflatoxin exposure. In: Eaton D.L., and Groopman J.D. (Eds). The Toxicology of Aflatoxins, Human Health, Veterinary and Agricultural Significance (1994), Academic Press Inc., New York 259-279
90. Groopman J.D., and Kensler T.W. Role of metabolism and viruses in aflatoxin-induced liver cancer. Toxicol. Appl. Pharmacol. 206 2 (2005) 131-137
91. Groopman J.D., Wang J.S., and Scholl P. Molecular biomarkers for aflatoxins: from adducts to gene mutations to human liver cancer. Can. J. Physiol. Pharmacol. 74 2 (1996) 203-209
92. Grove J.F. The trichothecenes and their biosynthesis. Fortschr. Chem. Org. Nat. 88 (2007) 63-130
93. Hadhoud S.E., Ismail S.A., and Youssef M.S. Aflatoxins in sera of pregnant woman and in neonatal cord blood: a possible causal agent in unexplained neonatal jaundice. J. Arab. Child 12 2 (2001) 209-232
94. Hendrickse R.G. Malnutrition and Mycotoxins (editorial). J. Trop. Paediatr. 2 (1982) 99-100
95. Hendrickse R.G. Kwashiorkor: 50 years of myth and mystery. Do aflatoxins provide a clue?. Acta Leiden. 53 (1985) 11-30
96. Hendrickse R.G. Of sick Turkeys, Kwashiorkor, malaria, perinatal mortality, Herion addicts and food poisoning: research on influence of aflatoxins on child health in the tropics. J. Trop. Med. Parasitol. 91 (1997) 87-93
97. Hendrickse K. Fumonisins and neural tube defects in south Texas. Epidemiology 10 (1999) 198-200
98. Hendrickse R.G., and Maxwell S.M. Aflatoxins and child health in the tropics. J. Toxicol.-Toxin Rev. 30 (1989) 795-805
99. Hendrickse K.A., Simpson J.S., and Larsen R.D. Neural tube defects along the Texas-Mexico border, 1993-1995. Am. J. Epidemiol. 149 (1999) 1119-1127
100. Henry C.I. Risk assessment, risk evaluation and risk management. In: de Vries J. (Ed). Food Safety and Toxicity (1997), CRC Press, Boca Raton, NY 283-300
101. Henry S.H., Bosch F.X., Troxell T.C., and Bolger P.M. Reducing liver cancer. Global control of aflatoxin. Science 286 (1999) 2453-2454
102. Henry, S.H., Bosch, X.F., Bowers, J.C., Bolger, P.M., 2000. Aflatoxin, hepatitis and worldwide liver cancer risks. In: Proceedings of the American Chemical Society Meeting, Washington, DC.
103. Herrman J.L., and Walker R. Risk analysis of mycotoxins by the joint FAO/WHO Expert Committee on Food Additives (JECFA). FNA 23 (1999) 17-21
104. Hesseltine C.W. Global significance of mycotoxins. In: Steyn P.S., and Vleggaar R. (Eds). Mycotoxins and Phycotoxins (1985) 1-18
105. Hill A.B. The environment and disease association or causation?. Proc. R. Soc. Med. 58 (1965) 295-300
106. Hoffman, F.O., Hammonds, J.S., 1992. An introductory guide to uncertainty analysis in environmental and health risk assessment, Martin Mareitta ES/ER/TM, 35.
107. Hoffman F.O., and Hammonds J.S. Propagation of uncertainty in risk assessment: the need to distinguish between uncertainty due to lack of knowledge and uncertainty due to variability. Risk Anal. 14 (1994) 707-711
108. Househam K.C., and Hundt H.K.L. Aflatoxin exposure and its relationship to Kwashiorkor in African children. J. Trop. Pediatr. 37 (1991) 300-302
109. Hsu I.C., Metcalf R.A., Sun T., Welsh J.A., Wang N.J., and Harris C.C. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 350 (1991) 427-431
110. IARC (International Agency for Research on Cancer), 1986. Summary & Evaluation, Patulin, vol. 40. Available at: 〈http://www.inchem.org/documents/iarc/vol40/patulin.html〉.
111. IARC. Aflatoxins. IARC Monographs on the evaluation of Carcinogenic Risks to Humans vol. 56 (1993), IARC, Lyon, France 243-395
112. IARC, 1993b. Ochratoxin A. In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 56. IARC, Lyon, France, pp. 489-521.
113. IARC. Toxins derived from Fusarium sporotrichioides: T-2 toxin. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans vol. 56 (1993), IARC, Lyon, France 467-488
114. IARC. Toxins derived from Fusarium graminearum: zearalenone, doxynivalenol and fusarenoneX. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans vol. 56 (1993), IARC, Lyon, France 397-444
115. ILSI, 2003. Trichothecenes with a special focus on DON .Summary report of a workshop held in September 2003 in Dublin, Ireland organized by the ILSI Europe natural toxin task force.
116. Jarvis B.B. Mycotoxins in food. In: Skinner F.A., and Carr J.G. (Eds). Symposium: Microbiology in Agricultural, Fisheries & Food (1976), Academic Press, London 251-267
117. Jarvis B.B. Chemistry and toxicology of molds isolated from water damaged buildings. In: deVries J.W., Trucksess M.W., and Jackson L.S. (Eds). Mycotoxins and Food Safety (2002), Kluwer Academic/Plenum Publications, New York, NY 43-52
118. Jelliffe D.B., and Jelliffe E.F. Causation of kwashiorkor; towards a multifactorial consensus. Pediatrics 90 1 (1992) 110-113
119. 1 albumin adduct levels and cellular immune status in Ghanaians. Int. Immunol. 17 (2005) 807-814
120. Jones B.D. Aflatoxin and related compounds, extraction and analysis. In: Wyllie T.D., and Morehouse L.G. (Eds). Mycotoxic Fungi, Mycotoxins, Mycotoxicosis VI III (1987), Marcel Dekker, New York, Basel 201-237
121. Jonsyn F.E., Maxwell S.M., and Hendrickse R.G. Human fetal exposure to ochratoxin A and aflatoxins. Ann. Trop. Paediatr. 15 1 (1995) 3-9
122. Kearns G.L., and Reed M.D. Clinical pharmaconkinetics in infants and children. A reappraisal. Clin. Pharmacokinet. 17 Suppl. 1 (1989) 29-67
123. Krishnamachari K.A., Nagaarajan V., Bhat R.V., and Tilak T.B. Hepatitis due to aflatoxicosis: an outbreak in Western India. Lancet 305 (1975) 1061-1063
124. Kuiper-Goodman T. Risk assessment to humans of mycotoxins in animal-derived food products. Vet. Hum. Toxicol. 33 (1991) 325-333
125. Kuiper-Goodman T. Approaches to the risk analysis of mycotoxins in the food supply. Food Nutr. Agric 23 (1999) 10-14
126. Kuiper-Goodman, T., 2004. Risk assessment and risk management of mycotoxins in food. In: Mogan, N., Olsen, M. (Eds.), Mycotoxins in Food, Detection and Control. CRC Press, New York; Wood head Publishing Limited, Cambridge, England, pp. 3-31 (Chapter 1).
127. Kuiper-Goodman T., and Scott P.M. Risk assessment of the mycotoxin ochratoxin A. Biomed. Environ. Sci. 2 (1989) 179-248
128. Kuiper-Goodman T., Scott P.M., and Watanabe H. Risk assessment of the mycotoxin zearalenone. Regul. Toxicol. Pharmacol. 7 (1987) 253-306
129. Kyle A.D., Woodruff T.J., and Axelrad D.A. Integrated assessment of environment and health: America's children and the environment. Environ. Health Perspect. 114 3 (2006) 447-452
130. Landrigan P.J., and Carlson J.E. Environmental policy and children's health. Future Child. 5 2 (1995) 34-52
131. Landrigan P.J., Carlson J.E., Bearer C.F., Spyker Cranmer J., Bullard R.D., Etzel R.A., Groopman J., McLachlan J.A., Perera F.P., Routt Reigart J., Robison L., Schell L., and Suk W.A. Children's health and the environment: a New Agenda for prevention research. Environ. Health Perspect. 106 Suppl. 3 (1998) 787-794
132. Larsen, J.C., Pascal, G., 2001. Applicability of the Acceptable Daily Intake (ADI) to infants and children. Consensus Report of a Workshop held 8-9 January 1997, Genval, Belgium organized By the ILSI Europe Acceptable Daily Intake Task Force ILSI Press, Washington, DC, second printing.
133. Lewis L., Onsongo M., Njapau H., Schurz-Rogers H., Luber G., Kieszak S., Nyamongo J., Backer L., Dahiye A.M., Misore A., Decoct K., and Rubin C. The Kenya Aflatoxicosis investigation group. Aflatoxin contamination of commercial maize products during an outbreak of acute aflatoxicosis in Eastern and Central Kenya. Environ. Health Perspect. 113 (2005) 1763-1767
134. Lombart G.A., Pellaers P., Roscoe V., Mankotia M., Neil R., and Scott P.M. Mycotoxins in infant cereal foods from the Canadian retail market. Food Addit. Contam. 20 5 (2003) 494-504
135. Lorenz K. Ergot on cereal grains. CRC Crit. Rev. Food Sci. Nutr. 11 (1979) 311-354
136. Lucarelli S., Corrado G., Pelliccia A., D'Ambrini G., Cavaliere M., Barbato M., Lendvai D., and Frediani T. Cyclic vomiting syndrome and food allergy/intolerance in seven children: a possible association. Eur. J. Pediatr. 159 5 (2000) 360-363
137. Luo X.Y. Outbreaks of moldy cereal poisonings in China. Toxicology Forum and the Chinese Academy of Preventive Medicine. Issues in Food Safety (1989), Toxicology Forum, Washington, DC 56-63
138. Marasas W.F.O. Discovery and occurrence of the fumonisins: a historical perspective. Environ. Health Perspect. 109 (2001) 239-243
139. Marasas W.F.O., Riley R.T., Hendricks K., Stevens V.L., Sadler T.W., Gelineau-van Waes J., Missmer S.A., Cabrera J., Torres O., Gelderblom W.C.A., Allegood J., Martýnez C., Maddox J., Miller J.D., Starr L., Sullards M.C., Roman A.V., Voss K.A., Wang E., and Merrill A.H. Fumonisins disrupt shingolipid metabolism, folate transport and neural tube development in embryo culture and in vivo: a potential risk factor for human neural tube defects among populations consuming fumonisin-contaminated maize. J. Nutr. 134 (2004) 711-716
140. Maxwell S.M. Investigations into the presence of aflatoxins in human body fluids and tissues in relation to child health in the tropics. Ann. Trop. Paediatr. 18 (1998) S41-S46
141. Merrill Jr. A.H., Sullards M.C., Wang E., Voss K.A., and Riley R.T. Sphingolipid metabolism: roles in signal transduction and disruption by fumonisins. Environ. Health Perspect. 109 (2001) 283-289
142. Missmer S., Hendricks K.A., Suarez L., Larsen R.D., and Rothman K.J. Fumonisins and neural tube defects: preliminary results from the Texas Department of Health. Epidemiology 11 (2000) 183-184
143. Missmer S.A., Suarez L., Felkner M., Wang E., Merrill Jr. A.H., Rothman K.J., and Hendricks K.A. Exposure to fumonisins and the occurrence of neural tube defects along the Texas-Mexico border. Environ. Health Perspect. 114 (2006) 237-241
144. Moore M.R. Risk assessment in environmental contamination and environmental health. In: Naidu R., Gupta V.V.S.R., Kookana R.S., Bolanm N.S., and Adriano D.C. (Eds). Bioavailability, Toxicity and Risk Relationships in Ecosystems (2003), Science Publishers, Inc., Enfield, USA, Plymouth, UK 3-19 (Chapter 1)
145. Morselli P.L. Clinical pharmacology of the perinatal period and early infancy. Clin. Pharmacokinet. 17 Suppl. 1 (1989) 13-28
146. Musser S.M., and Plattner R.D. Fumonisin composition in cultures of Fusarium moniliforme, Fusarium proliferatum and Fusarium nygami. J. Agric. Food Chem. 45 (1997) 1169-1173
147. Mwanda O.W., Otieno C.F., and Omonge E. Acute aflatoxicosis: case report. East Afr. Med. J. 82 6 (2005) 320-324
148. NAS. US National Academy of Science, Risk Assessment in the Federal Government: Managing the Process (1983), National Academy Press, Washington, DC
149. NAS. Pesticides in the Diets of Infants and Children (1993), National Academy Press, Washington, DC
150. NAS. Children's Health, the Nation's Wealth: Assessing and Improving Child Health (2004), National Academy Press, Washington, DC
151. 1 and ochratoxin A in a human milk bank in the city of Sao Paulo, Brazil. Food Addit. Contam. 22 (2005) 457-462
152. Ncayiyana D.J. Neural tube defects among rural blacks in a Transkei district. S. Afr. Med. J. 69 (1986) 618-620
153. 1 in human-derived in vitro systems. Toxicol. Appl. Pharmacol. 151 (1998) 152-158
154. Needham L.L., Özkaynak H., Whyatt R.M., Barr D.B., Wang R.Y., Naeher L., Akland G., Bahadori T., Bradman A., Fortmann R., Liu L.J., Morandi M., O'Rourke M.K., Thomas K., Quackenboss J., Ryan P.B., and Zartarian V. Exposure assessment in the national children's study. Environ. Health Perspect. 113 8 (2005) 1076-1082
155. Niyo K.A., Richard J.L., and Tiffany L.H. Effect of T-2 mycotoxin ingestion on phagocytosis of Aspergillus fumigatus conidia by rabbit alveolar macrophages and on hematologic, serum biochemical, and pathologic changes in rabbits. Am. J. Vet. Res. 49 (1988) 1766-1773
156. 1 and cyclopiazonic acid in fluid milk traded in São Paulo, Brazil. Food Addit. Contam. 23 (2006) 196-201
157. Oyelami O.A., Maxwell S.M., Adelusola K.A., Aladekoma T.A., and Olyelese A.O. Aflatoxins in the lungs of children with kwashiorkor and children with miscellaneous diseases in Nigeria. J. Toxicol. Environ. Health 51 (1997) 623-628
158. Patterson D.S.P. Aflatoxin and related compounds. In: Wyllie T.D., and Morehouse L.G. (Eds). Mycotoxic Fungi, Mycotoxins, Mycotoxicoses vol. III (1978), Marcel Dekker, Inc., New York, Basel 131-189
159. Paustenbach D.J. The Risk Assessment of Environmental and Human Health Hazards (1989), Wiley, New York p. 1121
160. Paustenbach D.J. The practice of exposure assessment. In: Hayes A.W. (Ed). Principles and Methods of Toxicology. fourth ed (2001), Taylor & Frances, Philadelphia, USA 378-448 (Chapter 9)
161. Peraica M., Radic B., Lucic A., and Pavlovic M. Toxic effects of mycotoxins in humans. Bull. World Health Organ. 77 (1999) 754-766
162. Perera F.P. Molecular epidemiology and prevention of cancer. Environ. Health Perspect. 103 Suppl. 8 (1995) 233-236
163. Pestka J.J., and Casale W.L. Naturally occurring fungal toxins. In: Hriaga J.O., and Simmons M.S. (Eds). Food Contamination from Environmental Sources (1990), Wiley, New York 613-638
164. Pestka J.J., and Smolinski A.T. Deoxynivalenol: toxicology and potential effects on humans. J. Toxicol. Environ. Health B 8 (2005) 39-69
165. Pestka J.J., Zhou H.R., Moon Y., and Chung Y.J. Cellular and molecular mechanisms for immunemodulation by deoxynivalenol and other trichothecenes: unraveling a paradox. Toxicol. Lett. 153 (2004) 61-73
166. Petkova-Bocharova T., and Castegnarom M. Ochratoxin A contamination of cereals in an area of high incidence of Balkan endemic nephropathy in Bulgaria. Food Addit. Contam. 2 (1985) 267-270
167. Petzinger E., and Weidenbach A. Mycotoxins in the food chain: the role of ochratoxins. Livestock Prod. Sci. 76 (2002) 245-250
168. Pillay D., Chuturgoonm A.A., Nevines E., Manickum T., Deppe W., and Dutton M.F. The quantitative analysis of zearalenone and its derivatives in plasma of patients with breast and cervical cancer. Clin. Chem. Lab. Med. 40 (2002) 946-951
169. Pitt J.I. What are mycotoxins?. Austral. Mycotoxin Newsletter 7 4 (1996) 1-3
170. Placinta C.M., D'Mello J.P.F., and Macdonald A.M.C. A review of worldwide contamination of cereal grains and animal feed with Fusarium mycotoxins. Anim. Feed Sci. Technol. 78 (1999) 21-37
171. Polychronaki N., Hannu M., Paul T.C., Yunyun G., Amra H., Abdel-Wahhab M.A., and El-Nezami H. Determinants of AFM1 in breast milk of Egyptian mothers. Food Addit. Contam. 23 7 (2006) 700-708
172. Polychronaki N., West R.M., Turner P.C., Amra H., Abdel-Wahhab M.A., Mykkänen H., and El-Nezami H. A longitudinal assessment of aflatoxin M1 excretion in breast milk of selected Egyptian mothers. Food Chem. Toxicol. 45 7 (2007) 1210-1215
173. Polychronaki N., Wild C.P., Mykkänen H., Amra H., Abdel-Wahhab M.A., Sylla A., Diallo M., El-Nezami H., and Turner C.P. Urinary biomarkers of aflatoxin exposure in young children from Egypt and Guinea. Food Chem. Toxicol. 46 2 (2008) 519-526
174. Prieta J., Moreno M.A., Diaz S., Suarez G., and Dominguez L. Survey of patulin in apple juice and children's apple foos by the diphase dialysis membrane procedure. J. Agric. Food Chem. 42 (1994) 1701-1703
175. Pullan A.J., and Smith N.P. Modeling, biomedical. In: Wnek G.E., and Bowlin G.L. (Eds). Encyclopedia of Biomaterials and Biomedical Engineering vol. 2: L-Z (2004), Marcel Dekker, Inc. 1026-1034
176. Qian G.S., Ross R.K., Yu M.C., Yuan J.M., Gao Y.T., Henderson B.E., Wogan G.N., and Groopman J.D. A follow up study of urinary markers of aflatoxin exposure and liver cancer in Shanghai, People's Republic of China. Cancer Epidemiol. Biomarkers Prev. 3 1 (1994) 3-10
177. 1. Food Additit. Contam. 18 3 (2001) 263-269
178. Randell A.W. Scientific basis for setting food standards through Codex Alimentarius. FNA (Rome) 31 (2002) 7-12
179. Rao G.J., Govindaraju G., Sivasithamparam N., and Shanmugasundaram E.R.B. Uptake, translocation and persistence of mycotoxins in rice seedings. Plant Soil 66 (1982) 121-123
180. Rees N., and Tennant D. Estimation of food chemical intake. In: Kostsonis F.N., Mackey M., and Hjeelle J. (Eds). Nutritional Toxicology (1994), Raven Press, New York 199-221
181. Renwick A.G. Data-derived safety factors for the evaluation of food additives and environmental contamination. Food Addit. Contam. 10 (1993) 275-305
182. Renwick A.G. Toxico-kinetics in infants and children in relation to the ADI and TDI. Food Addit. Contam. 15 (1998) 17-35
183. Rheeder J.P., Marasas W.F.O., and Vismer H.F. Production of fumonisin analogs by Fusarium species. Appl. Environ. Microbiol. 68 (2002) 2101-2105
184. Richard J.L. Mycotoxins as immunomodulators in animal systems. In: Bray G.A., and Ryan D.H. (Eds). Mycotoxins, Cancer, and Health, Pennington Center Nutrition Series (1991), Louisiana State University Press, Baton Rouge, LA 197-220
185. Rodricks J.V. Risk assessment, the environment, and public health. Environ. Health Perspect. 102 (1994) 258-264
186. Rodricks J.V. Risk communication between risk assessors and managers. FNA 31 (2002) 21-26
187. Rodricks, J.V., Park, D.L., 1983. General aspects of food safety and an illustration using aflatoxins. In: Naguib, K.H., Park, D.I., Pohland, A.E. (Eds.), Proceedings of the International Symposium on Mycotoxins, Cairo, Egypt, pp. 1-21.
188. Rosenthal E., Sala F., Batt M., and Cassuto J.P. Ergotism related to concurrent administration of ergotamine tartrate and indinavir. J. Am. Med. Assoc. 281 (1999) 987-991
189. Rutledge, A.E., 1976. The environmental-public health significance of mycotoxins. In: Proceedings of the First International Symposium on Feed Composition, Animal Nutrient Requirements, and Computerization of data. Utah State University, Logan, UT, pp. 345-350.
190. Saad A.M., Abdelgadir A.M., and Moss O.M. Exposure to aflatoxins M1 from mothers breast milk in Abu Dhabi, UAE. Food Addit. Contam. 12 (1995) 255-261
191. Saenz de Rodriguez C.A. Environmental hormone contamination in Puerto Rico. N. Engl. J. Med. 310 (1984) 1741-1742
192. Scheuplein R., Charnley G., and Dourson M. Differential sensitivity of children and adults to chemical toxicity. I: biological basis. Regul. Toxicol. Pharmacol. 35 (2002) 429-447
193. Schmidt C.W. Biomarkers in perspective. EHP 114 12A (2006) 701-705
194. Schoental R. Health hazards due to oestrogenic mycotoxins in certain foodstuffs. Int. J. Environ. Stud. 11 (1977) 149-150
195. Schoental R. Precocious sexual development in Puerto Rico and oestrogenic mycotoxins (zearalenone). Lancet I (1983) 537
196. Schothorst R.C., and van Egmond H.P. Report from SCOOP task 3.2.10 collection of occurrence data of Fusarium toxins in food and assessment of dietary intake by the population of EU member states. Subtask: trichothecenes. Toxicol. Lett. 153 (2004) 133-143
197. Schwartz G.G. Hypothesis: does ochratoxin A cause testicular cancer?. Cancer Causes Control 13 (2002) 91-100
198. Scudamore K.A. Mycotoxins. In: Watson D. (Ed). Natural Toxicants in Food (1998), Sheffield-CRC Press, New York 147-181
199. Semenza J.C., and Weasel L.H. Molecular epidemiology in environmental health: the potential of tumor suppressor gene p53 as a biomarker. Environ. Health Perspect. 105 Suppl. 1 (1997) 155-163
200. Sexton K., Klefman D., and Callahan M. An introduction to the national human exposure assessment survey and related phase 1 field studies. J. Expo. Anal. Environ. Epidemiol. 5 (1995) 221-232
201. Shank R.C. Mycotoxicoses of man: dietary and epidemiological consideration. In: Wyllie T.D., and Morehouse L.G. (Eds). Mycotoxin Fungi, Mycotoins, Mycotoxicosis. An Encyclopedic Handbook vol. I (1978), Marcel Dekker, Inc., New York, Basel 1-19
202. Shank R.C. Epidemiology of aflatoxin carcinogesis. In: Kraybill H.F., and Mehlman M.A. (Eds). Environmental Cancer (1977), Wiley, New York 291-318
203. Sharma R.P. Immunotoxicity of mycotoxins. J. Dairy Sci. 76 (1993) 892-897
204. Shephard G.S. Impact of mycotoxins on human health in developing countries. Food Addit. Contam. 25 2 (2008) 146-151
205. Sherif O.S. Mycotoxins and child health: of mycotoxicoses and food safety in Egypt: a search. Med. J. Cairo Univ. 71 (2003) 237-254
206. Sherif O.S. Mycotoxins and child health: assuring food safety in the globalization era. Med. J. Cairo Univ. 72 (2004) 103-127
207. Sherif O.S. Mycotoxins and child health: the risk analysis paradigm. Med. J. Cairo Univ. 74 (2006) 339-365
208. Shiefer H.B., and Beasley V.R. Effects on the digestive system and energy metabolism. In: Beasley V.R. (Ed). Trichothecene Mycotoxicosis: Pathophysiologic Effects vol. 2 (1989), CRC Press, Boca Raton, FL 61-89
209. Skaug M.A. Analysis of Norwegian milk and infant formulas for ochratoxin A. Food Addit. Contamin. 16 (1999) 75-78
210. Skipper P.L., and Tannenbaum S.R. Protein adducts in the molecular dosimetry of chemical carcinogens. Carcinogenesis 11 (1990) 507-518
211. Smith J.E. Aflatoxins. In: D'Mello F.J.P. (Ed). Plant and Fungal Toxicants (1997), CRC Press, Boca Raton, New York 269-285
212. Smith J.E., Solomons G., Lewis C., and Anderson J.G. Role of mycotoxins in human and animal nutrition and health. Nat. Toxins 3 (1995) 187-192
213. Sodeinde O., Chan M.C., Maxwell S.M., Familust J.B., and Hendricks R.G. Neonatal jaundice, aflatoxins and naphthols: report of study in Ibdan, Nigeria. Ann. Trop. Paediatr. 15 2 (1995) 107-113
214. Steinman R., Seigle-Murandi F., Sage L., and Krivobok S. Production of patulin by Micromycetes. Mycopathologia 105 (1989) 129-133
215. 1-induced sphyngolipid depletion inhibits vitamin uptake via the glycosylphosphatidylinositol-anchored folate receptor. J. Biol. Chem. 272 (1997) 18020-18025
216. Stoloff L., van Egmond H.P., and Park D.L. Rationales for the establishment of limits and regulations for mycotoxins. Food Addit. Contam. 8 (1991) 213-222
217. Szuets P., Mesterhazy A., Falkay G.Y., and Bartok T. Early telarche symptoms in children and their relations to zearalenone contamination in foodstuffs. Cereal Res. Commun. 25 (1997) 429-436
218. Tafuri A., Ferrance R., and Ritieni A. Ochratoxin A in Italian marketed cocoa products. Food Chem. 88 (2004) 487-494
219. Tamburlini G., Von Ehrenstein O.S., and Bertollini R. Children's Health and Environment: A Review of Evidence. A Joint Report from the European Environment Agency and the WHO Regional Office for Europe (2002), Office for Official Publications of the European Communities, Luxembourg
220. Tandon H., Tandon B., and Ramalingaswami V. Epidemic of toxic hepatitis in India of possible mycotoxic origin. Arch. Pathol. Lab. Med. 102 (1978) 372-376
221. Tanner M.S. Role of copper in Indian childhood cirrhosis. Am. J. Clin. Nutr. 67 5 Suppl. (1998) 1074S-1081S
222. 1 and ochratoxin A intoxication in pigs. Aust. Vet. J. 62 2 (1985) 33-37
223. 1 on body weight, antibody titres and histology of broiler chicks. Br. Poult. Sci. 47 3 (2006) 357-364
224. Thompson K.M. Changes in children's exposure as a function of age and the relevance of age definitions for exposure and health risk assessment. Medscape Gen. Med. 6 3 (2004) 2-6
225. Thomson C., and Henke S.E. Effects of climate and type of storage container on aflatoxin production in corn and its associated risks to wildlife species. J. Wildlife Dis. 36 (2000) 172-179
226. Turconi G., Guarcello M., Livieri C., Comizzoli S., Maccarini L., Castellazzi A.M., Pietri A., Pira G., and Roggi C. Evaluation of xenobiotics in human milk and ingestion by the newborn: an epidemiological survey in Lombardy (Northern Italy). Eur. J. Nutr. 43 (2004) 191-197
227. Turner P.C., Moore S.E., Hall A.J., Prentice A.M., and Wild C.P. Modification of immune function through exposure to dietary aflatoxin in Gambian children. Environ. Health Perspect. 111 (2003) 217-220
228. Van De Venter T. Emerging food-borne diseases: a global responsibility. FNA (FAO, Rome) 26 (2000) 4-12
229. van Egmond H.P., and Speijers G.A. Natural toxins I. Mycotoxins. In: van derHeijden K., Younes M., Fishbone L., and Miller S. (Eds). International Food Safety Handbook, Science, International Regulation, and Control (1999), Marcel Dekker, Inc., New York, Basel 342-355 (Chapter 20)
230. Venter P.A., Christiansen A.L., Humato C.M., Makhura M.P., and Gericke G.S. Congenital anomalies in rural black South African neonates-a silent epidemic. S. Afr. Med. J. 85 (1995) 15-20
231. Wallace R.B., Hoover L., Sandler D., Rifkind B.M., and Tyroler H.A. Altered plasma-lipids associated with oral contraceptive or oestrogen consumption: the research clinic program. Lancet 2 (1977) 11-14
232. Wanigasuriya K.P., Peiris H., Ileperuma N., Peiris-John R.J., and Wickremasinghe R. Could ochratoxin A in food commodities be the cause of chronic kidney disease in Sri Lanka?. Trans. R. Soc. Trop. Med. Hyg. (2008) 10.1016/j.trstmh. 2008.04.007
233. Watson D.H. Toxic fungal metabolites in food. CRC Crit. Rev. Food Sci. Nutr. 22 (1985) 177-198
234. Weidenborner M. Encyclopedia of Food Mycotoxins (2001), Springer, London
235. WHO, 1979. Environmental Health Criteria-11 (EHC-11): Mycotoxins.
236. WHO, 1983. Guidelines on Studies in Environmental Epidemiology (EHC-27), WHO, Geneva.
237. WHO, 1986. Principles for evaluating health risks from chemicals during infancy and early childhood; the need for a special approach, IPCS, Environmental Health Criteria 59, WHO, Geneva.
238. WHO, 1987. Principles for the Safety Assessment of Food Additives and Contaminants in Food, WHO, Geneva.
239. WHO, 1993. Biomarkers and risk assessment: concepts and principles, IPCS, WHO, Geneva.
240. WHO, 1999. Principles for the assessment of risk to human health from exposure to chemicals. Environmental Health Criteria 210, WHO, Geneva.
241. WHO. Evaluation and use of epidemiological evidence for environmental health risk assessment: WHO guideline document. Environ. Health Perspect. 108 (2000) 997-1002
242. WHO, 2000b. Evaluation of certain food additives and contaminants. Technical Report Series no. 896. WHO, Geneva.
243. WHO, 2001a. Safety evaluation of certain mycotoxins in food. Food and nutrition paper 74, World Health Organization, Geneva.
244. WHO, 2001b. Biomarkers in risk assessment: validity and validation. Environmental Health Criteria 222.
245. WHO, 2002. Evaluation of certain mycotoxins in food. Fifty-sixth report of the Joint FAO/WHO Expert Committee on Food Additives, WHO, Technical Report Series 906, WHO, Geneva.
246. WHO, 2006a. Principles for evaluating health risks in children associated with exposure to chemicals. Environmental Health Criteria 237.
247. WHO, 2006b. TRS-930, Evaluation of certain food contaminants, sixty-fourth report of the Joint FAO/WHO Committee on food additives. Technical Report Series 930, WHO, Geneva.
248. WHO/FAO, 1997. Safety evaluation of certain food additives and contaminants, FAS, 40. Prepared by the forty-ninth meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA). IPCS, WHO/FAO.
249. WHO/FAO, 2001. Safety evaluation of certain mycotoxins in food. WHO Food Additives series, 47-FAO, Food and Nutrition Paper 74, IPCS, WHO, Geneva.
250. Wild C.P., and Turner P.C. Exposure biomarkers in chemoprevetion studies of liver cancer. IARC Sci. Publ. 154 (2001) 215-222
251. Wild C.P., Rasheed F.N., Jowala M.F., Hall A.J., Jansen L.A.M., and Montessano R. In-utero exposure to aflatoxins in West Africa (a letter). Lancet 37 (1991) 1602-1604
252. Williams J.H., Phillips T.D., Jolly P.E., Stiles J.K., Jolly C.M., and Aggarwal D. Human aflatoxicosis in developing countries: a review of toxicology, exposure, potential health consequences, and interventions. Am. J. Clin. Nutr. 80 (2004) 1106-1122
253. Wogan G.N. Aflatoxins as a human carcinogen. Hepatology 3 (1999) 573-575
254. Wu F. Mycotoxin risk assessment for the purpose of setting international regulatory standards. Environ. Sci. Technol. 15 (2004) 4049-4055
255. 1 in human breast milk from the Gambia, West Africa, quantified by combined monoclonal antibody immunoaffinity chromatography and HPLC. Carcinogenesis 13 (1992) 891-894
256. Zimmerli B., and Dick R. Determination of ochratoxin A at the ppt level in human blood, serum, milk and some foodstuffs by high-performance liquid chromatography with enhanced fluorescence detection and immunoaffinity column cleanup: methodology and Swiss data. J. Chromatogr. B 666 (1995) 85-99